Exposure to circulating cobalt (Co
2+
) in patients with metal-on-metal orthopaedic hip implants has been linked to cardiotoxicity but the underlying mechanism(s) remain undefined. The aim of the current study was to examine the effects of Co
2+
on the heart in vivo and specifically on cardiac fibroblasts in vitro. Adult male rats were treated with CoCl
2
(1 mg/kg) for either 7 days or 28 days. Inductively coupled plasma mass spectrometry (ICP-MS) was used to measure Co
2+
uptake into various organs of the body. Co
2+
accumulated in the heart over time with significant levels evident after only 7 days of treatment. There was no evidence of cardiac remodelling following Co
2+
treatment as assessed by heart weight:body weight and left ventricular weight:body weight. However, a decrease in fractional shortening, as measured using echocardiography, was observed after 28 days of Co
2+
treatment. This was accompanied by increased protein expression of the ion transient receptor potential (TRP) channels TRPC6 and TRPM7 as assessed by quantitative immunoblotting of whole cardiac homogenates. Uptake of Co
2+
specifically into rat cardiac fibroblasts was measured over 72 h and was shown to dramatically increase with increasing concentrations of applied CoCl
2
. Expression levels of TRPC6 and TRPM7 proteins were both significantly elevated in these cells following Co
2+
treatment. In conclusion, Co
2+
rapidly accumulates to significant levels in the heart causing compromised contractility in the absence of any overt cardiac remodelling. TRPC6 and TRPM7 expression levels are significantly altered in the heart following Co
2+
treatment and this may contribute to the Co
2+
-induced cardiotoxicity observed over time.
Cobalt/chromium (Co/Cr) alloy metal-on-metal bearings used in prosthetic hip replacements can cause adverse effects in some patients because they release metal ions into the bloodstream during wear. Co toxicity may be a cause of many severe systemic manifestations including neurologic and cardiac symptomatology.This study examines the effects of chronic Co exposure in rats treated for 28 days with CoCl2 (single i.p. injection of 1 mg/kg, daily) and examines Co uptake in vitro into primary adult cardiac fibroblasts (CFs). Co treatment was associated with accumulation into various organs with significant increases detected in liver, kidney and heart (245.31±23.64, 204.80±11.19 and 41.04±4.77 µg/L respectively). Echocardiography performed on the same animals showed functional changes correlating with compromised cardiac contractility. Fractional shortening was significantly reduced in CoCl2–treated rats following 28 days treatment when compared with control animals (54.01%±0.90%% vs 60.29±0.53%%, n=6, p≤0.01) and there was evidence of diastolic dysfunction. In order to investigate how Co may accumulate in the heart, primary adult CFs were isolated and uptake of CoCl2 into CFs was compared with uptake into a standard fibroblast 3T3 cell line (3T3s). Uptake of metal ions was measured using inductively coupled plasma mass spectrometry. Co uptake into both 3T3s and CFs increased to between 0–50 and 0–120 µg/L, respectively as the medium concentration of Co (0–300 µM) increased. Interestingly, uptake of Co into CFs was significantly greater than into 3T3 cells. The greater accumulation of CoCl2 into CFs suggests that Co ions in vivo could accumulate in these cells and have functional consequences on cardiac performance. Overall, our data provides strong evidence that Co accumulates in the heart resulting in cardiac dysfunction. Importantly, we have shown for the first time that Co could accumulate in the heart via efficient uptake into CFs. Future work will focus on determining the underlying mechanism for uptake which could have important therapeutic implications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.